A timeline for predicting durable medical equipment needs and interventions for amyotrophic lateral sclerosis patients

被引:18
作者
Bromberg, Mark B. [1 ]
Brownell, Alexander A.
Forshew, Dallas A. [2 ]
Swenson, Michael [3 ]
机构
[1] Univ Utah, Dept Neurol, Clin Neurosci Ctr, Salt Lake City, UT 84132 USA
[2] Calif Pacific Med Ctr, Dept Neurol, San Francisco, CA USA
[3] Cent Wyoming Coll, Dept Math, Riverton, WY USA
来源
AMYOTROPHIC LATERAL SCLEROSIS | 2010年 / 11卷 / 1-2期
关键词
Amyotrophic lateral sclerosis; ALS; durable medical equipment; DME; ALS; CARE;
D O I
10.3109/17482960902835970
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ALS is progressive with increasing patient needs for durable medical equipment (DME) and interventions (gastric feeding tube - PEG, and non-invasive ventilation - NIV). We performed a chart review of deceased patients to determine the time-course of needs and their estimated costs. A timeline of needs was based on when clinic personnel felt an item was necessary. The point in time when an item or intervention was needed was expressed as a percentage of a patient's total disease duration. A wide range of DME and interventions was needed irrespective of site of ALS symptom onset (bulbar, upper, lower extremity), beginning at 10% of disease duration of lower extremity onset and increasing thereafter for all sites. The cumulative probability of costs of items and interventions began at 25%-50% of disease duration and increased to between $18,000 and $32,000 (USD), highest for lower extremity onset due to the cost of wheelchairs. We conclude that a high percentage of ALS patients will need a full spectrum of major DME items and interventions during the second half of disease duration. This results in a linear rise in costs over the second half of the disease duration.</.
引用
收藏
页码:110 / 115
页数:6
相关论文
共 12 条
  • [1] Prospective study of palliative care in ALS: choice, timing, outcomes
    Albert, SM
    Murphy, PL
    Del Bene, ML
    Rowland, LP
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 169 (1-2) : 108 - 113
  • [2] Good practice in the management of amyotrophic lateral sclerosis: Clinical guidelines. An evidence-based review with good practice points. EALSC Working Group
    Andersen, Peter Munch
    Borasio, Gian Domenico
    Dengler, Reinhard
    Hardiman, Orla
    Kollewe, Katja
    Leigh, Peter Nigel
    Pradat, Pierre-Francois
    Silani, Vincenzo
    Tomik, Barbara
    [J]. AMYOTROPHIC LATERAL SCLEROSIS, 2007, 8 (04): : 195 - 213
  • [3] Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis
    Beghi, Ettore
    Millul, Andrea
    Logroscino, Giancarlo
    Vitelli, Eugenio
    Micheli, Anna
    [J]. AMYOTROPHIC LATERAL SCLEROSIS, 2008, 9 (03): : 163 - 167
  • [4] Brooks BR, 1996, NEUROLOGY, V47, pS71, DOI 10.1212/WNL.47.4_Suppl_2.71S
  • [5] BROOKS BR, 1996, NEUROLOGY S2, V47, pS2
  • [6] BROOKS BR, 1990, CONTROLLED CLIN TRIA, P249
  • [7] Brachial amyotrophic diplegia - A slowly progressive motor neuron disorder
    Katz, JS
    Wolfe, GI
    Andersson, PB
    Saperstein, DS
    Elliott, JL
    Nations, SP
    Bryan, WW
    Barohn, RJ
    [J]. NEUROLOGY, 1999, 53 (05) : 1071 - 1076
  • [8] Kimura Fumiharu, 2007, Rinsho Shinkeigaku, V47, P140
  • [9] The economic impact of ALS
    Klein, LM
    Forshew, DA
    [J]. NEUROLOGY, 1996, 47 (04) : S126 - S129
  • [10] Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
    Miller, RG
    Rosenberg, JA
    Gelinas, NF
    Mitsumoto, H
    Newman, D
    Sufit, R
    Borasio, GD
    Bradley, WG
    Bromberg, MB
    Brooks, BR
    Kasarskis, EJ
    Munsat, TL
    Oppenheimer, EA
    [J]. NEUROLOGY, 1999, 52 (07) : 1311 - 1323